Skip to content
Medical Health Aged Care

‘We must act; young lives are at risk’: Tassie GPs call for free Meningococcal B vaccine expansion

Royal Australian College of GPs 2 mins read

GPs are urging the Tasmanian Government to follow the lead of other states and territories and fund the expansion of a life-saving Meningococcal B vaccination program for at-risk patient groups. 

It comes following the Royal Australian College of GPs (RACGP) stepping up calls for all state and territory governments to fund free Meningococcal B vaccines for children aged two-and-under, and every adolescent aged 1519-years-old.   

The College has spoken out recently following the tragic death of 16-year-old Levi Syer, and warmly welcomed the Tasmanian Government’s commitment to make meningococcal B vaccines free for all infants from six weeks to 12 months old and free catch-up immunisation for children over 12 months and under two years old. 

However, RACGP Tasmania Chair Dr Toby Gardner said further expansion is needed. 

“We must act; young lives are at risk,” he said. 

“It’s time for Tasmania to catch up. Other state and territory governments have already rolled out free vaccination funding programs for children and adolescents, including South Australia, Queensland, and the Northern Territory, as well as a commitment from the Western Australian Opposition. 

“This is a severe bacterial infection that can rapidly take the lives of otherwise young and healthy teenagers. If we don’t act to boost vaccination rates, young people with their whole lives ahead of them will succumb to untimely deaths, and we can’t let that happen.” 

Dr Gardner urged the Tasmanian Government to step up to help families with teenagers across the state. 

“Households are facing high cost-of-living pressures, and we must ensure all families can access these potentially lifesaving vaccinations,” he said. 

“The price for the Meningococcal B vaccine can range from $110 to $135 per dose, and two or three doses may be needed depending on age. So, by ensuring the Meningococcal B vaccine is free of charge for at-risk groups across our state, we can save lives. 

The RACGP Tasmania Chair said Meningococcal B must be taken seriously. 

“This is a very serious infection that kills 510% of patients. For those who survive, 1020% are left with brain damage, hearing loss or a learning disability,” Dr Gardner said. 

“Increasing vaccination rates is the number one thing we can do to save lives. If we don’t initiate a free vaccination program, unfortunately some families may not be able to afford vaccinations for teenagers. And one young life lost is too many. 

“We must act now, particularly since we have a safe and effective vaccine available. In Tasmania, we just need the political will to make it more accessible for more families with teenagers; by doing so we can save precious young lives.”  

~ENDS 

RACGP spokespeople are available for interviews: 03 8699 0992 / [email protected]. 


About us:

About the RACGP 

The Royal Australian College of General Practitioners (RACGP) is the peak representative organisation for general practice, the backbone of Australia’s health system. We set the standards for general practice, facilitate lifelong learning for GPs, connect the general practice community, and advocate for better health and wellbeing for all Australians. 

Visit www.racgp.org.au. To unsubscribe from RACGP media releases, click here. 


Contact details:

Media team: 03 8699 0992 / [email protected] 

 

Follow us on X/Twitter: @RACGP and Facebook. 

 

More from this category

  • Medical Health Aged Care, Political
  • 16/01/2026
  • 06:00
Monash University

National genomic screening program would save thousands of Australians from preventable cancer and heart disease

Leadinggenomic health experts from Monash University are calling for urgent government funding to progress the development of a national preventive genomic testing program that would save thousands of Australians from conditions like cancer and heart disease. This call to action follows a Monash-led nationwide pilot study recently completed, offering free genomic screening to 10,000 Australians aged 18 to 40. The pilot tested for 10 medically actionable genes linked to hereditary breast and ovarian cancer, Lynch syndrome, and familial hypercholesterolaemia. The findings are published today in the inaugural edition of the new academic journal Nature Health. The pilot study was led…

  • Medical Health Aged Care
  • 16/01/2026
  • 00:11
QPS Holdings, LLC

QPS Selects Oracle Argus Safety Database to Enhance Pharmacovigilance in Clinical Trials

NEWARK, Del.–BUSINESS WIRE– QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of…

  • Contains:
  • Medical Health Aged Care
  • 15/01/2026
  • 23:11
WHOOP

WHOOP and Samuel Ross MBE Announce Multiyear, Global Creative Partnership, Introducing a New Era in Performance Fashion

The WHOOP x SR_A collaboration ushers in a new frontier of performance accessories, apparel, and design-driven technology BOSTON–BUSINESS WIRE– WHOOP, the human performance company,…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.